The mechanosensitive Piezo1 channel is required for bone formation

Abstract

Mechanical load of the skeleton system is essential for the development, growth, and maintenance of bone. However, the molecular mechanism by which mechanical stimuli are converted into osteogenesis and bone formation remains unclear. Here we report that Piezo1, a bona fide mechanotransducer critical for various biological processes, plays a critical role in bone formation. Knockout of Piezo1 in osteoblast lineage cells disrupts osteogenesis of osteoblasts and severely impairs bone structure and strength. Mechanical unloading induced bone loss is blunted in the Piezo1 knockout mice. Intriguingly, simulated microgravity treatment reduced the function of osteoblasts via suppressing the expression of Piezo1. Furthermore, osteoporosis patients show reduced expression of Piezo1, which is closely correlated with osteoblast dysfunction. These data collectively suggest that Piezo1 functions as a key mechanotransducer for conferring mechanosensitivity to osteoblasts and determining mechanical-load-dependent bone formation, and represents a novel therapeutic target for treating osteoporosis or mechanical unloading-induced severe bone loss.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Weijia Sun

    State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  2. Shaopeng Chi

    State Key Laboratory of Membrane Biology, Tsinghua University, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  3. Yuheng Li

    State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  4. Shukuan Ling

    State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  5. Yingjun Tan

    State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  6. Youjia Xu

    The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  7. Fan Jiang

    State Key Laboratory of Membrane Biology, Tsinghua University, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  8. Jianwei Li

    State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  9. Caizhi Liu

    State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  10. Guohui Zhong

    State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  11. Dengchao Cao

    State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  12. Xiaoyan Jin

    State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  13. Dingsheng Zhao

    State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  14. Xingcheng Gao

    State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  15. Zizhong Liu

    State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  16. Bailong Xiao

    State Key Laboratory of Membrane Biology, Tsinghua University, Beijing, China
    For correspondence
    xbailong@mail.tsinghua.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
  17. Yingxian Li

    State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China
    For correspondence
    yingxianli@aliyun.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5440-3281

Funding

National Natural Science Foundation of China (31630038)

  • Yingxian Li

National Natural Science Foundation of China (81822026)

  • Shukuan Ling

National Natural Science Foundation of China (91740114)

  • Yingxian Li

National Natural Science Foundation of China (81830061)

  • Yingxian Li

National Natural Science Foundation of China (31700741)

  • Yuheng Li

National Natural Science Foundation of China (31825014)

  • Bailong Xiao

National Natural Science Foundation of China (31630090)

  • Bailong Xiao

Ministry of Science and Technology of the People's Republic of China (2016YFA0500402)

  • Bailong Xiao

Ministry of Science and Technology of the People's Republic of China (2015CB910102)

  • Bailong Xiao

National Natural Science Foundation of China (31800994)

  • Weijia Sun

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal studies were performed according to approved guidelines for the use and care of live animals (Guideline on Administration of Laboratory Animals released in1988 and 2006 Guideline on Humane Treatment of Laboratory Animals from China). All the experimental procedures were approved by the Committees of Animal Ethics and Experimental Safety of China Astronaut Research and Training Center (Reference number: ACC-IACUC-2017-003).

Human subjects: The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki. All the clinical procedures were approved by the Committees of Clinical Ethics in the Second Affiliated Hospital of Soochow University (Reference number: 2016-K-22).

Copyright

© 2019, Sun et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 10,989
    views
  • 1,847
    downloads
  • 257
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Weijia Sun
  2. Shaopeng Chi
  3. Yuheng Li
  4. Shukuan Ling
  5. Yingjun Tan
  6. Youjia Xu
  7. Fan Jiang
  8. Jianwei Li
  9. Caizhi Liu
  10. Guohui Zhong
  11. Dengchao Cao
  12. Xiaoyan Jin
  13. Dingsheng Zhao
  14. Xingcheng Gao
  15. Zizhong Liu
  16. Bailong Xiao
  17. Yingxian Li
(2019)
The mechanosensitive Piezo1 channel is required for bone formation
eLife 8:e47454.
https://doi.org/10.7554/eLife.47454

Share this article

https://doi.org/10.7554/eLife.47454

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Kristina Ehring, Sophia Friederike Ehlers ... Kay Grobe
    Research Article

    The Sonic hedgehog (Shh) signaling pathway controls embryonic development and tissue homeostasis after birth. This requires regulated solubilization of dual-lipidated, firmly plasma membrane-associated Shh precursors from producing cells. Although it is firmly established that the resistance-nodulation-division transporter Dispatched (Disp) drives this process, it is less clear how lipidated Shh solubilization from the plasma membrane is achieved. We have previously shown that Disp promotes proteolytic solubilization of Shh from its lipidated terminal peptide anchors. This process, termed shedding, converts tightly membrane-associated hydrophobic Shh precursors into delipidated soluble proteins. We show here that Disp-mediated Shh shedding is modulated by a serum factor that we identify as high-density lipoprotein (HDL). In addition to serving as a soluble sink for free membrane cholesterol, HDLs also accept the cholesterol-modified Shh peptide from Disp. The cholesteroylated Shh peptide is necessary and sufficient for Disp-mediated transfer because artificially cholesteroylated mCherry associates with HDL in a Disp-dependent manner, whereas an N-palmitoylated Shh variant lacking C-cholesterol does not. Disp-mediated Shh transfer to HDL is completed by proteolytic processing of the palmitoylated N-terminal membrane anchor. In contrast to dual-processed soluble Shh with moderate bioactivity, HDL-associated N-processed Shh is highly bioactive. We propose that the purpose of generating different soluble forms of Shh from the dual-lipidated precursor is to tune cellular responses in a tissue-type and time-specific manner.

    1. Cell Biology
    Parijat Biswas, Priyanka Roy ... Deepak Kumar Sinha
    Research Article

    The excessive cosolute densities in the intracellular fluid create a physicochemical condition called macromolecular crowding (MMC). Intracellular MMC entropically maintains the biochemical thermodynamic equilibria by favouring associative reactions while hindering transport processes. Rapid cell volume shrinkage during extracellular hypertonicity elevates the MMC and disrupts the equilibria, potentially ushering cell death. Consequently, cells actively counter the hypertonic stress through regulatory volume increase (RVI) and restore the MMC homeostasis. Here, we establish fluorescence anisotropy of EGFP as a reliable tool for studying cellular MMC and explore the spatiotemporal dynamics of MMC during cell volume instabilities under multiple conditions. Our studies reveal that the actin cytoskeleton enforces spatially varying MMC levels inside adhered cells. Within cell populations, MMC is uncorrelated with nuclear DNA content but anti-correlated with the cell spread area. Although different cell lines have statistically similar MMC distributions, their responses to extracellular hypertonicity vary. The intensity of the extracellular hypertonicity determines a cell's ability for RVI, which correlates with Nuclear Factor Kappa Beta (NFkB) activation. Pharmacological inhibition and knockdown experiments reveal that Tumour Necrosis Factor Receptor 1 (TNFR1) initiates the hypertonicity induced NFkB signalling and RVI. At severe hypertonicities, the elevated MMC amplifies cytoplasmic microviscosity and hinders Receptor Interacting Protein Kinase 1 (RIPK1) recruitment at the TNFR1 complex, incapacitating the TNFR1-NFkB signalling and consequently, RVI. Together, our studies unveil the involvement of TNFR1-NFkB signalling in modulating RVI and demonstrate the pivotal role of MMC in determining cellular osmoadaptability.